The rebirth of isolated organ contraction studies for drug discovery and repositioning

被引:0
|
作者
Borges, Ricardo [1 ]
机构
[1] Univ La Laguna, Med Sch, Pharmacol Unit, E-38200 Tenerife, Spain
关键词
Antihypertensive; Aorta; Bronchodilators; Isolated tissues; Organ bath; Trachea;
D O I
10.1016/j.drudis.2021.11.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Smooth muscle contraction is a basic homeostatic mechanism and, when dysfunctional, it is directly responsible for severe diseases like asthma and arterial hypertension. For decades, the standard technique to study contraction and evaluate the action of drugs has involved the use of isolated organ baths. However, the high cost of the dedicated personnel has led to their progressive replacement by techniques compatible with HTS. Nevertheless, preclinical evaluation of vasodilator or bronchodilator activity still requires direct evaluation of a drug's effects. The multi-well organ bath (MuWOB) combines the possibility of using a robot to perform computer-controlled contraction and relaxation assays on arterial and tracheal tissue (rings) in largescale parallel analyses.
引用
收藏
页码:1128 / 1131
页数:4
相关论文
共 50 条
  • [1] Drug Repositioning An Approach for Drug Discovery
    Vora, Parin K.
    Somani, Rakesh R.
    Jain, Madhuri H.
    MINI-REVIEWS IN ORGANIC CHEMISTRY, 2016, 13 (05) : 363 - 376
  • [2] Repositioning Natural Products in Drug Discovery
    Rastelli, Giulio
    Pellati, Federica
    Pinzi, Luca
    Gamberini, Maria Cristina
    MOLECULES, 2020, 25 (05):
  • [4] DrugCentral 2021 supports drug discovery and repositioning
    Avram, Sorin
    Bologa, Cristian G.
    Holmes, Jayme
    Bocci, Giovanni
    Wilson, Thomas B.
    Dac-Trung Nguyen
    Curpan, Ramona
    Halip, Liliana
    Bora, Alina
    Yang, Jeremy J.
    Knockel, Jeffrey
    Sirimulla, Suman
    Ursu, Oleg
    Oprea, Tudor, I
    NUCLEIC ACIDS RESEARCH, 2021, 49 (D1) : D1160 - D1169
  • [5] Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
    Zhu, Sha
    Bai, Qifeng
    Li, Lanqing
    Xu, Tingyang
    Computational and Structural Biotechnology Journal, 2022, 20 : 2839 - 2847
  • [6] Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
    Zhu, Sha
    Bai, Qifeng
    Li, Lanqing
    Xu, Tingyang
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 2839 - 2847
  • [7] Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu, Niteshkumar U.
    Kharkar, Prashant S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (19) : 2069 - 2077
  • [8] Computational drug repositioning for ischemic stroke: neuroprotective drug discovery
    Li, Yunong
    Yang, Jingbo
    Zhang, Yan
    Meng, Qingkang
    Bender, Andreas
    Chen, Xiujie
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (15) : 1271 - 1283
  • [9] Drug repositioning: Progress and challenges in drug discovery for various diseases
    Hua, Yi
    Dai, Xiaowen
    Xu, Yuan
    Xing, Guomeng
    Liu, Haichun
    Lu, Tao
    Chen, Yadong
    Zhang, Yanmin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 234
  • [10] Drug repositioning can accelerate discovery of pharmacological chaperones
    Mele, Bruno Hay
    Citro, Valentina
    Andreotti, Giuseppina
    Cubellis, Maria Vittoria
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10